NCT03007147 2026-02-23
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Children's Oncology Group
Phase 3 Active not recruiting
Children's Oncology Group
Dana-Farber Cancer Institute
Phoenix Children's Hospital
Dana-Farber Cancer Institute
Children's Oncology Group